** India's Nifty 50 .NSEI and Sensex .BSESN overcome a
lacklustre start to rise 0.5%, led by IT and pharma companies
** IT firms .NIFTYIT , which earn a significant share of
revenue from the U.S., gain about 2% ahead of U.S. inflation
data on Weds that could influence the size of a Federal Reserve
rate cut next week
** Markets expect a 25 bps cut, but softer-than-expected
data would boost the chances of a 50 bps cut, and that could
also spur a global stocks rally, says Sunny Agrawal, head of
fundamental equity research at SBICaps Securities
** Pharma index .NIPHARM gains 1.1% after India recommends
a tax cut on select cancer drugs
** A tax cut on savoury snacks boosts Gopal Snacks GOPA.NS
by 9%, while Prataap Snacks PRAT.NS and Bikaji Foods BIKA.NS
gain about 3% each
(Reporting by Bharath Rajeswaran in Bengaluru)
((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))